Watch Ticker

Lipocine Inc.

Go to Lipocine Inc. Website

$3.10

0.02 (0.49%)

Live

Previous Close

$3.08

Day Range

$3.05 - $3.095

Previous Day Range

$3.08 - $3.2537

Market Cap

$16.7 million USD

Day Vol.

5091

Previous Day Vol.

64849

Currency

USD

Primary Exchange

Nasdaq

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing dr...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The sarcopenia market remains largely untapped, with significant unmet medical needs and no approved drug therapies. However, pharmaceutical interest is rising, particularly around muscle-enhancing agents and anti-inflammatory pathways. Regulatory bodies are beginning to recognize sarcopenia as a distinct clinical condition, which may streamline future drug approvals.

Related tickers: BPTSY, TNFA, LPCN.

Read Full Article

Julian Ross - Lipozem Reviews (2025): Consumer Reports on Lipozem Weight Loss Formula

Lipozem, a turmeric-based supplement, claims to address the root cause of stubborn weight gain - inflammation within fat cells. Consumer reports highlight remarkable weight loss results, with some users losing over 90 lbs in just 3 months. The supplement's unique formula, developed by Dr. Julian Ross, targets inflammation directly, enabling natural and sustained fat burning.

Related tickers: LPCN.

Read Full Article

Trending Tickers

Please sign in to view